Krystal Biotech, Inc. KRYS Return on equity

Return on equity at other companies

Sarepta Therapeutics, Inc.SRPT

-9.3%+2,662pp

Ultragenyx PharmaceuticalRARE

-325.6%+36.9pp

Viridian Therapeutics, Inc.VRDN

-65.7%-0.1pp

RegenxbioRGNX

-137.6%-817pp

Zevra Therapeutics, Inc.ZVRA

34.8%+31.3pp

Kyverna Therapeutics, Inc.KYTX

-74.5%+74.4pp

FAQ

What is Krystal Biotech, Inc.'s return on equity?

Krystal Biotech, Inc. (KRYS) reported return on equity of 19.9% in Q1 2026.

How has Krystal Biotech, Inc.'s return on equity changed year-over-year?

Krystal Biotech, Inc.'s return on equity increased by 43.2% year-over-year, from 13.9% to 19.9%.

What is the long-term trend for Krystal Biotech, Inc.'s return on equity?

Over 5 years (2020 to 2025), Krystal Biotech, Inc.'s return on equity has grown at a 7.8% compound annual growth rate (CAGR), from -13% to 18.9%.

What does return on equity mean?

Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.